ASHP Releases Report on National Drug Shortages for March 2025

The number of active drug shortages stands at 270, which has remained fairly steady over the past three quarters.

The American Society of Health-System Pharmacists (ASHP) has released a report on national drug shortages from January 2001 to March 2025.

The number of active drug shortages currently is 270, “virtually unchanged for the past three quarters, but down from an all-time high in the first quarter of 2024.”

Hurricane Helene’s disruptions to supply chains remain a concern for manufacturing, as shortages remain of certain “critical and life-saving fluids.” That said, more than one-third of active shortages (41%) “began in 2022 or earlier.” In 2024, the majority of the reasoning for shortages was either unknown or unprovided (55%), but 17% pointed the finger at manufacturing and 9% blamed the hurricane or “business decision” broadly.

Another concern is that “workload required to manage shortages, including work to change pharmacy automation and electronic health records, adds to the challenges of pharmacy staff shortages.”

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates